Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice
Authors:
- Luis F. GonzálezLGLuis F. González
- Francisca Henríquez-BelmarFHFrancisca Henríquez-Belmar
- Claudia Delgado-AcevedoCDClaudia Delgado-Acevedo
- Marisol Cisternas-OlmedoMCMarisol Cisternas-Olmedo
- Gloria ArriagadaGAGloria Arriagada
- Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
- Dennis L. MurphyDMDennis L. Murphy
- Pablo R. MoyaPMPablo R. Moya
Open Access
- 19 September 2017
- journal article
- research article
- Published by Springer Nature in Biological Research
- Vol. 50 (1) , 29
Abstract
Obsessive–compulsive disorder (OCD) is a severe neuropsychiatric condition affecting 1–3% of the worldwide population. OCD has a strong genetic component, and the SLC1A1 gene that encodes neuronal glutamate transporter EAAT3 is a strong candidate for this disorder. To evaluate the impact of reduced EAAT3 expression in vivo, we studied male EAAT3 heterozygous and wild-type littermate mice using a battery of behavioral paradigms relevant to anxiety (open field test, elevated plus maze) and compulsivity (marble burying), as well as locomotor activity induced by amphetamine. Using high-performance liquid chromatography, we also determined tissue neurotransmitter levels in cortex, striatum and thalamus—brain areas that are relevant to OCD. Compared to wild-type littermates, EAAT3 heterozygous male mice have unaltered baseline anxiety-like, compulsive-like behavior and locomotor activity. Administration of acute amphetamine (5 mg/kg intraperitoneally) increased locomotion with no differences across genotypes. Tissue levels of glutamate, GABA, dopamine and serotonin did not vary between EAAT3 heterozygous and wild-type mice. Our results indicate that reduced EAAT3 expression does not impact neurotransmitter content in the corticostriatal circuit nor alter anxiety or compulsive-like behaviors.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (1141272, 1160398)
- National Institute of Mental Health (Intramural Research Program)
- Ministerio de Economía, Fomento y Turismo (Iniciativa Científica Milenio, Núcleo Milenio NC 130011)
This publication has 37 references indexed in Scilit:
- Parasynaptic NMDA Receptor Signaling Couples Neuronal Glutamate Transporter Function to AMPA Receptor Synaptic Distribution and StabilityThe Journal of Neuroscience, 2012
- The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorderPharmacology Biochemistry and Behavior, 2012
- Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout miceBMC Pharmacology, 2011
- Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduriaJournal of Clinical Investigation, 2011
- Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in miceNature Medicine, 2010
- Neuronal Transporters Regulate Glutamate Clearance, NMDA Receptor Activation, and Synaptic Plasticity in the HippocampusJournal of Neuroscience, 2009
- A family‐based association study of the glutamate transporter gene SLC1A1 in obsessive–compulsive disorder in 378 familiesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- A Haplotype Containing Quantitative Trait Loci for SLC1A1 Gene Expression and Its Association With Obsessive-Compulsive DisorderArchives of General Psychiatry, 2009
- Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant miceNature, 2007
- The developing use of heterozygous mutant mouse models in brain monoamine transporter researchTrends in Pharmacological Sciences, 2007